Canada markets open in 1 hour 6 minutes

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
61.73+0.30 (+0.49%)
At close: 04:00PM EDT
61.73 0.00 (0.00%)
After hours: 05:29PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.29B
Enterprise Value 1.37B
Trailing P/E 38.34
Forward P/E 14.56
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.26
Price/Book (mrq)2.86
Enterprise Value/Revenue 2.64
Enterprise Value/EBITDA 10.78

Trading Information

Stock Price History

Beta (5Y Monthly) 0.81
52-Week Change 332.24%
S&P500 52-Week Change 328.04%
52 Week High 370.81
52 Week Low 344.27
50-Day Moving Average 366.63
200-Day Moving Average 359.87

Share Statistics

Avg Vol (3 month) 3162.17k
Avg Vol (10 day) 3167.72k
Shares Outstanding 520.96M
Implied Shares Outstanding 620.96M
Float 815.69M
% Held by Insiders 111.12%
% Held by Institutions 177.89%
Shares Short (Apr 30, 2024) 4229.92k
Short Ratio (Apr 30, 2024) 41.73
Short % of Float (Apr 30, 2024) 41.42%
Short % of Shares Outstanding (Apr 30, 2024) 41.10%
Shares Short (prior month Mar 28, 2024) 4197.03k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 18, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 6.87%
Operating Margin (ttm)10.95%

Management Effectiveness

Return on Assets (ttm)3.91%
Return on Equity (ttm)8.71%

Income Statement

Revenue (ttm)517.46M
Revenue Per Share (ttm)27.70
Quarterly Revenue Growth (yoy)28.70%
Gross Profit (ttm)N/A
EBITDA 112.38M
Net Income Avi to Common (ttm)30.55M
Diluted EPS (ttm)1.61
Quarterly Earnings Growth (yoy)1,165.30%

Balance Sheet

Total Cash (mrq)238.25M
Total Cash Per Share (mrq)12.28
Total Debt (mrq)290.51M
Total Debt/Equity (mrq)60.93%
Current Ratio (mrq)3.95
Book Value Per Share (mrq)23.26

Cash Flow Statement

Operating Cash Flow (ttm)115.8M
Levered Free Cash Flow (ttm)79.33M